SPP1 (Osteopontin) serves as a principal regulator of aberrant ECM remodeling and is prevalent in numerous conditions, including cancer, cardiovascular illness, pulmonary disease, chronic renal disease, and osteoarthritis. Here, SPP1 is linked to osteoarthritis.